PepGen Total Liabilities Growth & History (PEPG)
PepGen's total liabilities was $26.5M for fiscal 2025.
View full PepGen company overviewPepGen annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $26.5M | −$5.8M | −17.98% |
| 2024 | 2024-12-31 | $32.3M | −$2.4M | −6.84% |
| 2023 | 2023-12-31 | $34.6M | −$3.2M | −8.41% |
| 2022 | 2022-12-31 | $37.8M | $27.3M | +258.48% |
| 2021 | 2021-12-31 | $10.5M | — | — |
PepGen quarterly total liabilities
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $21.9M | −$9.2M | −29.66% |
| Q1 2026 | 2026-03-31 | $22.3M | −$13.3M | −37.30% |
| Q4 2025 | 2025-12-31 | $26.5M | −$5.8M | −17.98% |
| Q3 2025 | 2025-09-30 | $26.9M | −$5.9M | −17.88% |
| Q2 2025 | 2025-06-30 | $31.1M | −$7.4M | −19.20% |
| Q1 2025 | 2025-03-31 | $35.6M | $7.6M | +27.10% |
| Q4 2024 | 2024-12-31 | $32.3M | −$2.4M | −6.84% |
| Q3 2024 | 2024-09-30 | $32.8M | −$5.6M | −14.65% |
| Q2 2024 | 2024-06-30 | $38.5M | $3.7M | +10.54% |
| Q1 2024 | 2024-03-31 | $28.0M | −$8.2M | −22.64% |
| Q4 2023 | 2023-12-31 | $34.6M | −$3.2M | −8.41% |
| Q3 2023 | 2023-09-30 | $38.4M | $22.9M | +147.48% |
| Q2 2023 | 2023-06-30 | $34.8M | $14.2M | +69.13% |
| Q1 2023 | 2023-03-31 | $36.2M | $19.9M | +122.21% |
| Q4 2022 | 2022-12-31 | $37.8M | $27.3M | +258.48% |
| Q3 2022 | 2022-09-30 | $15.5M | — | — |
| Q2 2022 | 2022-06-30 | $20.6M | — | — |
| Q1 2022 | 2022-03-31 | $16.3M | — | — |
| Q4 2021 | 2021-12-31 | $10.5M | — | — |
PepGen total liabilities trends
Between the periods ended 2021-12-31 and 2025-12-31, PepGen's total liabilities increased from $10.5M to $26.5M, a change of $15.9M. The latest reported quarter, Q2 2026, shows $21.9M.
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PepGen source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...